Proposed neuroimaging criteria for the diagnosis of multiple system atrophy
Identifieur interne : 001658 ( Main/Corpus ); précédent : 001657; suivant : 001659Proposed neuroimaging criteria for the diagnosis of multiple system atrophy
Auteurs : David J. Brooks ; Klaus SeppiSource :
- Movement Disorders [ 0885-3185 ] ; 2009-05-15.
English descriptors
- KwdEn :
Abstract
In this article, we review the state of the art knowledge concerning structural and functional imaging in multiple system atrophy (MSA). The relative value of imaging modalities in the differential diagnosis of MSA from other parkinsonian syndromes is debated. It is concluded that, although neuroimaging biomarkers provide valuable supportive data alongside clinical assessments, it is not possible to use them as surrogate markers. © 2009 Movement Disorder Society
Url:
DOI: 10.1002/mds.22413
Links to Exploration step
ISTEX:A109B1B2226401DFB6195F293512AAB002850D6CLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Proposed neuroimaging criteria for the diagnosis of multiple system atrophy</title><author><name sortKey="Brooks, David J" sort="Brooks, David J" uniqKey="Brooks D" first="David J." last="Brooks">David J. Brooks</name><affiliation><mods:affiliation>Division of Neuroscience, Faculty of Medicine, Imperial College London, London, United Kingdom</mods:affiliation></affiliation></author><author><name sortKey="Seppi, Klaus" sort="Seppi, Klaus" uniqKey="Seppi K" first="Klaus" last="Seppi">Klaus Seppi</name><affiliation><mods:affiliation>Department of Neurology, University of Innsbruck, Innsbruck, Austria</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:A109B1B2226401DFB6195F293512AAB002850D6C</idno><date when="2009" year="2009">2009</date><idno type="doi">10.1002/mds.22413</idno><idno type="url">https://api.istex.fr/document/A109B1B2226401DFB6195F293512AAB002850D6C/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">001658</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Proposed neuroimaging criteria for the diagnosis of multiple system atrophy</title><author><name sortKey="Brooks, David J" sort="Brooks, David J" uniqKey="Brooks D" first="David J." last="Brooks">David J. Brooks</name><affiliation><mods:affiliation>Division of Neuroscience, Faculty of Medicine, Imperial College London, London, United Kingdom</mods:affiliation></affiliation></author><author><name sortKey="Seppi, Klaus" sort="Seppi, Klaus" uniqKey="Seppi K" first="Klaus" last="Seppi">Klaus Seppi</name><affiliation><mods:affiliation>Department of Neurology, University of Innsbruck, Innsbruck, Austria</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2009-05-15">2009-05-15</date><biblScope unit="volume">24</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="949">949</biblScope><biblScope unit="page" to="964">964</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">A109B1B2226401DFB6195F293512AAB002850D6C</idno><idno type="DOI">10.1002/mds.22413</idno><idno type="ArticleID">MDS22413</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>MRI</term><term>PET</term><term>Parkinson</term><term>SPECT</term><term>multiple system atrophy</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In this article, we review the state of the art knowledge concerning structural and functional imaging in multiple system atrophy (MSA). The relative value of imaging modalities in the differential diagnosis of MSA from other parkinsonian syndromes is debated. It is concluded that, although neuroimaging biomarkers provide valuable supportive data alongside clinical assessments, it is not possible to use them as surrogate markers. © 2009 Movement Disorder Society</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>David J. Brooks MD, Dsc, FRCP</name><affiliations><json:string>Division of Neuroscience, Faculty of Medicine, Imperial College London, London, United Kingdom</json:string></affiliations></json:item><json:item><name>Klaus Seppi MD</name><affiliations><json:string>Department of Neurology, University of Innsbruck, Innsbruck, Austria</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>multiple system atrophy</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Parkinson</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>MRI</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>PET</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>SPECT</value></json:item></subject><articleId><json:string>MDS22413</json:string></articleId><language><json:string>eng</json:string></language><abstract>In this article, we review the state of the art knowledge concerning structural and functional imaging in multiple system atrophy (MSA). The relative value of imaging modalities in the differential diagnosis of MSA from other parkinsonian syndromes is debated. It is concluded that, although neuroimaging biomarkers provide valuable supportive data alongside clinical assessments, it is not possible to use them as surrogate markers. © 2009 Movement Disorder Society</abstract><qualityIndicators><score>5.816</score><pdfVersion>1.3</pdfVersion><pdfPageSize>612 x 810 pts</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>5</keywordCount><abstractCharCount>466</abstractCharCount><pdfWordCount>9507</pdfWordCount><pdfCharCount>62695</pdfCharCount><pdfPageCount>16</pdfPageCount><abstractWordCount>68</abstractWordCount></qualityIndicators><title>Proposed neuroimaging criteria for the diagnosis of multiple system atrophy</title><corporate><json:item><name>for the Neuroimaging Working Group on MSA</name></json:item></corporate><genre><json:string>review-article</json:string></genre><host><volume>24</volume><publisherId><json:string>MDS</json:string></publisherId><pages><total>16</total><last>964</last><first>949</first></pages><issn><json:string>0885-3185</json:string></issn><issue>7</issue><subject><json:item><value>Review</value></json:item></subject><genre><json:string>Journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1531-8257</json:string></eissn><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><publicationDate>2009</publicationDate><copyrightDate>2009</copyrightDate><doi><json:string>10.1002/mds.22413</json:string></doi><id>A109B1B2226401DFB6195F293512AAB002850D6C</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/A109B1B2226401DFB6195F293512AAB002850D6C/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/A109B1B2226401DFB6195F293512AAB002850D6C/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/A109B1B2226401DFB6195F293512AAB002850D6C/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Proposed neuroimaging criteria for the diagnosis of multiple system atrophy</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>WILEY</p></availability><date>2009</date></publicationStmt><notesStmt><note type="content">*Potential conflict of interest: DJB works for GE health care. KS has no disclosure.</note><note type="content">*This article is part of the journal's online CME program. The CME activity including form, can be found online at http://www.movementdisorders.org/education/journalcme/</note><note>NIH (National Institute of Neurological Disorders and Stroke) - No. 1 R13 NS055459;</note><note>Novartis Pharmaceuticals</note><note>Chelsea Therapeutics</note><note>American Academy of Neurology (AAN)</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Proposed neuroimaging criteria for the diagnosis of multiple system atrophy</title><author><orgName>for the Neuroimaging Working Group on MSA</orgName></author><author><persName><forename type="first">David J.</forename><surname>Brooks</surname></persName><roleName type="degree">MD, Dsc, FRCP</roleName><note type="correspondence"><p>Correspondence: Division of Neuroscience, Faculty of Medicine, Imperial College London, London, United Kingdom===</p></note><affiliation>Division of Neuroscience, Faculty of Medicine, Imperial College London, London, United Kingdom</affiliation></author><author><persName><forename type="first">Klaus</forename><surname>Seppi</surname></persName><roleName type="degree">MD</roleName><affiliation>Department of Neurology, University of Innsbruck, Innsbruck, Austria</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2009-05-15"></date><biblScope unit="volume">24</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="949">949</biblScope><biblScope unit="page" to="964">964</biblScope></imprint></monogr><idno type="istex">A109B1B2226401DFB6195F293512AAB002850D6C</idno><idno type="DOI">10.1002/mds.22413</idno><idno type="ArticleID">MDS22413</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2009</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>In this article, we review the state of the art knowledge concerning structural and functional imaging in multiple system atrophy (MSA). The relative value of imaging modalities in the differential diagnosis of MSA from other parkinsonian syndromes is debated. It is concluded that, although neuroimaging biomarkers provide valuable supportive data alongside clinical assessments, it is not possible to use them as surrogate markers. © 2009 Movement Disorder Society</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>multiple system atrophy</term></item><item><term>Parkinson</term></item><item><term>MRI</term></item><item><term>PET</term></item><item><term>SPECT</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>article category</head><item><term>Review</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2007-08-30">Received</change><change when="2008-11-05">Registration</change><change when="2009-05-15">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/A109B1B2226401DFB6195F293512AAB002850D6C/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="70"><doi origin="wiley" registered="yes">10.1002/mds.v24:7</doi><numberingGroup><numbering type="journalVolume" number="24">24</numbering><numbering type="journalIssue">7</numbering></numberingGroup><coverDate startDate="2009-05-15">15 May 2009</coverDate></publicationMeta><publicationMeta level="unit" type="reviewArticle" position="1" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.22413</doi><idGroup><id type="unit" value="MDS22413"></id></idGroup><countGroup><count type="pageTotal" number="16"></count></countGroup><titleGroup><title type="articleCategory">Review</title><title type="tocHeading1">Reviews</title></titleGroup><copyright ownership="thirdParty">Copyright © 2009 Movement Disorder Society</copyright><eventGroup><event type="manuscriptReceived" date="2007-08-30"></event><event type="manuscriptRevised" date="2008-10-30"></event><event type="manuscriptAccepted" date="2008-11-05"></event><event type="firstOnline" date="2009-03-20"></event><event type="publishedOnlineFinalForm" date="2009-05-28"></event><event type="publishedOnlineAcceptedOrEarlyUnpaginated" date="2009-03-20"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:3.3.3 mode:FullText" date="2014-07-24"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.3.3 mode:FullText" date="2014-07-24"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">949</numbering><numbering type="pageLast">964</numbering></numberingGroup><correspondenceTo>Division of Neuroscience, Faculty of Medicine, Imperial College London, London, United Kingdom===</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS22413.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="3"></count><count type="tableTotal" number="5"></count><count type="referenceTotal" number="105"></count><count type="wordTotal" number="11768"></count></countGroup><titleGroup><title type="main" xml:lang="en">Proposed neuroimaging criteria for the diagnosis of multiple system atrophy<link href="#fn6"></link> <link href="#fn7"></link></title><title type="short" xml:lang="en">Neuroimaging Criteria for the Diagnosis of MSA</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><givenNames>David J.</givenNames><familyName>Brooks</familyName><degrees>MD, Dsc, FRCP</degrees></personName><contactDetails><email>david.brooks@csc.mrc.ac.uk</email></contactDetails></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Klaus</givenNames><familyName>Seppi</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au3" creatorRole="author"><groupName>for the Neuroimaging Working Group on MSA</groupName></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="GB" type="organization"><unparsedAffiliation>Division of Neuroscience, Faculty of Medicine, Imperial College London, London, United Kingdom</unparsedAffiliation></affiliation><affiliation xml:id="af2" countryCode="AT" type="organization"><unparsedAffiliation>Department of Neurology, University of Innsbruck, Innsbruck, Austria</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">multiple system atrophy</keyword><keyword xml:id="kwd2">Parkinson</keyword><keyword xml:id="kwd3">MRI</keyword><keyword xml:id="kwd4">PET</keyword><keyword xml:id="kwd5">SPECT</keyword></keywordGroup><fundingInfo><fundingAgency>NIH (National Institute of Neurological Disorders and Stroke)</fundingAgency><fundingNumber>1 R13 NS055459</fundingNumber></fundingInfo><fundingInfo><fundingAgency>Novartis Pharmaceuticals</fundingAgency></fundingInfo><fundingInfo><fundingAgency>Chelsea Therapeutics</fundingAgency></fundingInfo><fundingInfo><fundingAgency>American Academy of Neurology (AAN)</fundingAgency></fundingInfo><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>In this article, we review the state of the art knowledge concerning structural and functional imaging in multiple system atrophy (MSA). The relative value of imaging modalities in the differential diagnosis of MSA from other parkinsonian syndromes is debated. It is concluded that, although neuroimaging biomarkers provide valuable supportive data alongside clinical assessments, it is not possible to use them as surrogate markers. © 2009 Movement Disorder Society</p></abstract></abstractGroup></contentMeta><noteGroup><note xml:id="fn6"><p>Potential conflict of interest: DJB works for GE health care. KS has no disclosure.</p></note><note xml:id="fn7"><p>This article is part of the journal's online CME program. The CME activity including form, can be found online at http://www.movementdisorders.org/education/journalcme/</p></note></noteGroup></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Proposed neuroimaging criteria for the diagnosis of multiple system atrophy</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Neuroimaging Criteria for the Diagnosis of MSA</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Proposed neuroimaging criteria for the diagnosis of multiple system atrophy</title></titleInfo><name type="personal"><namePart type="given">David J.</namePart><namePart type="family">Brooks</namePart><namePart type="termsOfAddress">MD, Dsc, FRCP</namePart><affiliation>Division of Neuroscience, Faculty of Medicine, Imperial College London, London, United Kingdom</affiliation><description>Correspondence: Division of Neuroscience, Faculty of Medicine, Imperial College London, London, United Kingdom===</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Klaus</namePart><namePart type="family">Seppi</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology, University of Innsbruck, Innsbruck, Austria</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="corporate"><namePart>for the Neuroimaging Working Group on MSA</namePart><description>Division of Neuroscience, Faculty of Medicine, Imperial College London, London, United KingdomDepartment of Neurology, University of Innsbruck, Innsbruck, Austria</description></name><typeOfResource>text</typeOfResource><genre type="review-article" displayLabel="reviewArticle"></genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">2009-05-15</dateIssued><dateCaptured encoding="w3cdtf">2007-08-30</dateCaptured><dateValid encoding="w3cdtf">2008-11-05</dateValid><copyrightDate encoding="w3cdtf">2009</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="figures">3</extent><extent unit="tables">5</extent><extent unit="references">105</extent><extent unit="words">11768</extent></physicalDescription><abstract lang="en">In this article, we review the state of the art knowledge concerning structural and functional imaging in multiple system atrophy (MSA). The relative value of imaging modalities in the differential diagnosis of MSA from other parkinsonian syndromes is debated. It is concluded that, although neuroimaging biomarkers provide valuable supportive data alongside clinical assessments, it is not possible to use them as surrogate markers. © 2009 Movement Disorder Society</abstract><note type="content">*Potential conflict of interest: DJB works for GE health care. KS has no disclosure.</note><note type="content">*This article is part of the journal's online CME program. The CME activity including form, can be found online at http://www.movementdisorders.org/education/journalcme/</note><note type="funding">NIH (National Institute of Neurological Disorders and Stroke) - No. 1 R13 NS055459; </note><note type="funding">Novartis Pharmaceuticals</note><note type="funding">Chelsea Therapeutics</note><note type="funding">American Academy of Neurology (AAN)</note><subject lang="en"><genre>Keywords</genre><topic>multiple system atrophy</topic><topic>Parkinson</topic><topic>MRI</topic><topic>PET</topic><topic>SPECT</topic></subject><relatedItem type="host"><titleInfo><title>Movement Disorders</title></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><genre type="Journal">journal</genre><subject><genre>article category</genre><topic>Review</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>24</number></detail><detail type="issue"><caption>no.</caption><number>7</number></detail><extent unit="pages"><start>949</start><end>964</end><total>16</total></extent></part></relatedItem><identifier type="istex">A109B1B2226401DFB6195F293512AAB002850D6C</identifier><identifier type="DOI">10.1002/mds.22413</identifier><identifier type="ArticleID">MDS22413</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2009 Movement Disorder Society</accessCondition><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001658 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001658 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= ISTEX:A109B1B2226401DFB6195F293512AAB002850D6C
|texte= Proposed neuroimaging criteria for the diagnosis of multiple system atrophy
}}
| This area was generated with Dilib version V0.6.23. |  |